Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Toner

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
European Urology|January 1, 1991
Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumorsH W Herr, G C Toner, N L Geller, et al.
Radiology|May 1, 1990
Nonseminomatous germ cell tumors: enlarging masses despite chemotherapyD M Panicek, G C Toner, R T Heelan, et al.
Cancer Research|September 15, 1990
Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumorsG C Toner, N L Geller, C Tan, et al.
American Journal of Clinical Oncology|June 1, 1997
Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancerM Michael, G C Toner, I N Olver, et al.
Acta Haematologica|January 1, 1989
Central nervous system lymphoma: primary lumbar nerve root infiltrationG C Toner, R Holmes, R A Sinclair, et al.
The Medical Journal of Australia|August 1, 1994
The spectrum of 5-fluorouracil cardiotoxicityS A McLachlan, M J Millward, G C Toner, et al.
Annals of Internal Medicine|May 15, 1989
Colony-stimulating factors and neutrophil migrationG C Toner, A A Jakubowski, J P Crown, et al.
Autoimmunity|January 1, 1989
Autoantibodies to neurons and to the cytoskeleton in small cell carcinoma with paraneoplastic sensory neuropathyF Alderuccio, J M Rolland, G C Toner, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 1, 1998
A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervixN Tebbutt, D Rischin, M Quinn, et al.
Gynecologic Oncology|October 1, 1996
Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxelJ D Shapiro, M J Millward, D Rischin, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
European Urology|January 1, 1991
Patient selection for retroperitoneal lymph node dissection after chemotherapy for nonseminomatous germ cell tumorsH W Herr, G C Toner, N L Geller, et al.
Radiology|May 1, 1990
Nonseminomatous germ cell tumors: enlarging masses despite chemotherapyD M Panicek, G C Toner, R T Heelan, et al.
Cancer Research|September 15, 1990
Serum tumor marker half-life during chemotherapy allows early prediction of complete response and survival in nonseminomatous germ cell tumorsG C Toner, N L Geller, C Tan, et al.
American Journal of Clinical Oncology|June 1, 1997
Phase I dose intensification study of 2-weekly epirubicin with GM-CSF in advanced cancerM Michael, G C Toner, I N Olver, et al.
Acta Haematologica|January 1, 1989
Central nervous system lymphoma: primary lumbar nerve root infiltrationG C Toner, R Holmes, R A Sinclair, et al.
The Medical Journal of Australia|August 1, 1994
The spectrum of 5-fluorouracil cardiotoxicityS A McLachlan, M J Millward, G C Toner, et al.
Annals of Internal Medicine|May 15, 1989
Colony-stimulating factors and neutrophil migrationG C Toner, A A Jakubowski, J P Crown, et al.
Autoimmunity|January 1, 1989
Autoantibodies to neurons and to the cytoskeleton in small cell carcinoma with paraneoplastic sensory neuropathyF Alderuccio, J M Rolland, G C Toner, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|April 1, 1998
A phase II trial of carboplatin and etoposide for relapsed or metastatic carcinoma of the cervixN Tebbutt, D Rischin, M Quinn, et al.
Gynecologic Oncology|October 1, 1996
Activity of gemcitabine in patients with advanced ovarian cancer: responses seen following platinum and paclitaxelJ D Shapiro, M J Millward, D Rischin, et al.
Pageof 6